TrialPloS one2013

Low prevalence of liver disease but regional differences in HBV treatment characteristics mark HIV/HBV co-infection in a South African HIV clinical trial.

Prudence Ive et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.